Box score
Xenagos Bio, Inc.
Reported $2.5M sold in a new Form D filed May 15, 2026 (Philadelphia, Pennsylvania).
- Biggest raise
- $2.5M filed May 15, 2026
- League
- Bio & Health Biotechnology
- Based in
- Philadelphia, Pennsylvania
- Season rank
- #479 of 1,121 in the Bio & Health League; #4075 of 10,745 overall (2026)
- Incorporated
- 2025
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-05-15 | New notice | $2.5M | $2.5M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2134608.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Ovala, Inc. | Bio & Health | $3.3M |
| 2 | Glycotest Inc. rookie | Bio & Health | $3.2M |
| 3 | Cantai Therapeutics, Inc. | Bio & Health | $3M |
| 4 | NexEos Diagnostics, Inc. | Bio & Health | $3M |
| 5 | Praeventix, Inc. | Bio & Health | $3M |
| 6 | Aethl Bio, Inc. rookie | Bio & Health | $1.6M |